Please login to the form below

Nycomed

This page shows the latest Nycomed news and features for those working in and with pharma, biotech and healthcare.

Two other investigations - involving AstraZeneca/Nycomed and Teva/Cephalon - did not result in enforcement action by the Commission.

Shire signs deal to buy NPS for $5.2bn

Takeda's Nycomed subsidiary.
Lundbeck CEO resigns after rule breach

Wiinberg's departure is immediate and Lundbeck's chairman Björklund - former CEO of Nycomed - will act as day-to-day leader of the company until a successor is found.
EU hits Servier and generic firms with €428m 'pay-for-delay' fine

case involving AstraZeneca (AZ) and Nycomed was dropped in 2012.
FDA knocks back Durect's painkiller

A year earlier, Takeda, through its subsidiary Nycomed, announced it had agreed to hand back its rights for Posidur.
EC fines J&J and Novartis in pay-for-delay case

A case involving AstraZeneca and Nycomed was dropped last year. Earlier this year Danish pharma company Lundbeck was fined almost 94m for a pay-for-delay deal involving its antidepressant

More from news
Approximately 1 fully matching, plus 71 partially matching documents found.

Forging a path in specialty care

In recent years Takeda has joined in the industry's enthusiasm for mergers and acquisitions, notably of Millennium in Boston, Massachusetts and Nycomed headquartered in Zurich, Switzerland.
Pharma deals during May 2014

in Europe, Meda (rejected bid from Mylan), AMco and previously Nycomed (now owned by Takeda).
Pharma deals during October 2013

licensing agreement it inherited through its acquisition of Nycomed.
Putin - pharma’s friend or foe in Russia?

For Nycomed the investment in Russia resulted in total sales in region of 640m in 2010. ... For Putin it had even larger implications - the success of Nycomed proved he was on to a winning strategy.
Pharma deals during June 2013

Nycomed had originally developed the drug, which it had licensed to Wyeth.

More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.

Janssen's Matthew Kirby takes up senior role at Wilmington Healthcare

Before joining Janssen Kirby was at Nycomed Pharmaceuticals, where he served in a market access capacity as a healthcare development specialist.
Sobi appoints Torbjorn Hallberg as general counsel

He arrives at Sobi will more than 15 years’ experience covering licensing, mergers and acquisitions at pharma groups such as Ferring and Nycomed.
Dominic Moorhead joins Ferring Pharmaceuticals

for Takeda Pharmaceuticals, and CFO of the international business following the acquisition of Nycomed..
Bo Jesper Hansen to step down as chairman of Sobi

Björklund served as chief executive officer at Nycomed until 2011 and oversaw its growth from a largely Scandinavian business into a global pharmaceutical company operating across Europe, Latin America and Russia.
Eisai names new US financial head

Lederman was most recently chief financial officer at Wedgewood Pharmacy, a subsidiary of Nycomed in the US.

More from appointments
Approximately 0 fully matching, plus 7 partially matching documents found.

Country Manager, Healthcare Communications Agency, Germany: Highly competitive salary

Add my company

For those who can imagine better, Page & Page and Partners (P&P) is home to meaningful encounters of a marketing, communication...

The communication challenge of helping he next generation to be healthier: As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?: We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
How the Royal Society’s EiR programme can help to drive UK innovation: ...

Email:
Password: